Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Author:

Chen Qiuyan12,Tang Linquan12,Liu Na1,Han Feng13,Guo Ling12,Guo Shanshan12,Wang Jianwei13,Liu Huai4,Ye Yanfang5,Zhang Lu6,Liu Liting12,Wang Pan12,Li Yingqin1,He Qingmei1,Yang Xiaoqun1,Tang Qingnan12,Li Yang12,Liang YuJing12,Sun XueSong12,Xie Chuanmiao17,Mo Yunxian17,Guo Ying18,Sun Rui12,Mo Haoyuan12,Cao Kajia12,Guo Xiang12,Zeng Musheng1,Mai Haiqiang12,Ma Jun19ORCID

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

2. Department of Nasopharyngeal Carcinoma; Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

3. Department of Ultrasound; Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

4. Department of Radiation Oncology, Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine; Central South University; Changsha 410013 P. R. China

5. Department of Science and Education; Sun Yat-sen Memorial Hospital; Guangzhou 510060 P. R. China

6. Department of Radiation Oncology; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou 510060 P. R. China

7. Department of Imaging; Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

8. Department of Clinical Trial Center; Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

9. Department of Radiation Oncology; Sun Yat-sen University Cancer Center; Guangzhou 510060 P. R. China

Funder

Jiangsu Hengrui Medicine Co., Ltd

The National Science & Technology Pillar Program during the Twelfth Five-year Plan Period

The Natural Science Foundation of Guangdong Province

The Science and Technology Project of Guangzhou City, China

The Health & Medical Collaborative Innovation Project of Guangzhou City, China

The Innovation Team Development Plan of the Ministry of Education

The Program of Introducing Talents of Discipline to Universities

the National Natural Science Foundation of China

the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period

the Natural Science Foundation of Guangdong Province

the Science and Technology Project of Guangzhou City, China

the Health & Medical Collaborative Innovation Project of Guangzhou City, China

the Innovation Team Development Plan of the Ministry of Education

the Program of Introducing Talents of Discipline to Universities

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3